MAPT and Alzheimer disease: Together, the downregulation of core presynaptic and scaffolding proteins alongside the upregulation of stress‐responsive regulators aligns with previous reports of ENS dysfunction in AD, including neuronal loss, cholinergic deficits, impaired motility, and amyloid/tau accumulation.81, 82, 83